Coya Therapeutics, Inc. (COYA) Misses Q2 EPS by 42c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q2 EPS of ($0.19), $0.42 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $3.43 million.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• Trump: Scott Bessent will not be going to be super intelligence (SI) czar
• Blackstone’s top private-equity executive Joseph Baratta is preparing to leave firm - WSJ
• H.C. Wainwright Reiterates Buy Rating on Coya Therapeutics (COYA)